Every Form 4 that Schrodinger, Inc. (SDGR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SDGR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SDGR filings page.
Schrodinger, Inc. (SDGR) reported that executive Karen Akinsanya, President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships, exercised options for 31,599 shares of common stock at an exercise price of $4.34 per share on September 17, 2026, from a fully vested option granted on November 29, 2018. On the same day, she sold 10,000 shares at $28.00 and 21,599 shares at $30.00, in total selling the 31,599 shares acquired, pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2025; a remaining option position of 11,599 shares is reported, and her equity holdings include 63,545 unvested RSUs.
Schrodinger, Inc. EVP & CFO Rachit Jain reported selling 875 shares of common stock on July 16, 2026, at a weighted average price of $15.597 per share. The broker-assisted sale was executed under a Rule 10b5-1 durable automatic instruction to satisfy withholding tax liability from vested RSUs and is not a discretionary trade. Following the sale, Jain directly holds 50,877 shares, which include 43,154 unvested RSUs.
Schrodinger, Inc. director Richard Friesner reported estate-planning transfers involving Schrodinger common stock. Two bona fide gifts totaling 1,358,746 shares were made on June 26, 2026 through entities described as the RF 2018 GRAT and a grantor retained annuity trust, with shares now held by the RF 2018 Family Trust and similar vehicles rather than sold on the market.
Following these changes, Friesner is shown as directly owning 705,917 shares of common stock, which include 8,141 unvested RSUs and 2,335 shares transferred from the RF 2018 GRAT. An additional 28,328 shares are reported as indirectly owned through his spouse. Shares held by the Family Trust, where his spouse is a trustee and his children are beneficiaries, are reported with a disclaimer of beneficial ownership except for any pecuniary interest.
Schrodinger, Inc. director Arun Oberoi reported equity awards consisting of common stock and stock options granted as compensation. He received 8,141 shares of common stock at no cost, structured as restricted stock units under the company’s 2022 Equity Incentive Plan. These RSUs were granted on June 22, 2026 and will vest on the twelve-month anniversary of the grant date, or earlier if the next annual meeting of stockholders occurs sooner, subject to continued service. He was also granted a stock option for 13,313 shares of common stock at an exercise price of $15.23 per share, expiring on June 22, 2036, with the same vesting schedule. Following these awards, Oberoi directly holds 25,388 shares of common stock, which includes the 8,141 unvested RSUs.
Schrodinger, Inc. director Jeffrey Chodakewitz reported equity awards rather than open-market trades. He received 8,141 restricted stock units (RSUs), each representing one future share of common stock, and 13,313 stock options with an exercise price of $15.23 per share.
The RSUs and options were granted on June 22, 2026 and are scheduled to vest on the twelve-month anniversary of grant, or earlier if the next annual stockholder meeting occurs sooner, subject to continued service. Following the RSU grant, his direct common stock holdings total 25,388 shares, including 8,141 unvested RSUs. The stock options are scheduled to expire on June 22, 2036. Settlement of the RSUs is deferred until separation from service or certain change in control events.
Schrodinger, Inc. director Richard Friesner reported new equity awards and updated share holdings. He received 8,141 restricted stock units (RSUs) under the 2022 Equity Incentive Plan, each representing one share of common stock. These RSUs vest on the 12‑month anniversary of the June 22, 2026 grant date, or earlier if the next annual shareholder meeting occurs sooner, subject to continued service.
Friesner was also granted a stock option for 13,313 shares of common stock at an exercise price of $15.23 per share, expiring in 2036 and vesting on the same schedule. Following these awards, he holds 690,365 common shares directly, which include the 8,141 unvested RSUs, plus indirect holdings of 28,328 shares held by his spouse and 694,925 shares held by the RF 2018 grantor retained annuity trust.
Schrodinger, Inc. director Gary L. Ginsberg received new equity awards consisting of restricted stock units and stock options as part of his compensation. He was granted 8,141 RSUs, each representing a contingent right to one share of common stock. These RSUs were granted on June 22, 2026 and will vest on the twelve-month anniversary of the grant date, or earlier if the next annual stockholder meeting occurs sooner, subject to continued service. He also received a stock option for 13,313 shares of common stock at an exercise price of $15.23 per share, expiring on June 22, 2036, with the same vesting schedule. Following these grants, he directly holds 25,388 shares of common stock, which include the 8,141 unvested RSUs.
Schrodinger, Inc. director Rosana Kapeller-Libermann reported equity awards in the form of stock and options. She received 8,141 restricted stock units (RSUs), each representing one share of common stock, under the 2022 Equity Incentive Plan. Following this grant, she directly holds 25,388 shares of common stock, including 8,141 unvested RSUs.
The RSUs were granted on June 22, 2026 and are scheduled to vest on the twelve‑month anniversary of the grant date, or earlier if the next annual stockholder meeting occurs sooner, subject to continued service. Settlement of these RSUs will be deferred until the earlier of 30 days after her separation from service or certain change in control events.
She was also granted a stock option covering 13,313 shares of common stock at an exercise price of $15.23 per share, expiring on June 22, 2036. This option is set to vest on the same schedule as the RSUs, tied to continued service with the company.
Schrödinger, Inc. director Michael Lynton received new equity awards as part of his compensation. He was granted 8,141 restricted stock units under the company’s 2022 Equity Incentive Plan, each representing one share of common stock. These RSUs vest on the earlier of the twelve‑month anniversary of the June 22, 2026 grant date or the next annual shareholder meeting, subject to continued service, and settlement is deferred until separation from service or certain change in control events.
He also received a stock option covering 13,313 shares of common stock at an exercise price of $15.23 per share, vesting on the same schedule. Following these grants, he directly holds 25,388 shares of common stock, including the 8,141 unvested RSUs, and 13,313 stock options that expire on June 22, 2036.
Schrodinger, Inc. director Gary Sender received new equity awards as part of his compensation. He was granted 8,141 restricted stock units, each representing one future share of common stock, under the company’s 2022 Equity Incentive Plan. These RSUs were granted on June 22, 2026 and will vest after about one year or at the next annual shareholder meeting, subject to continued service.
Sender was also granted stock options for 13,313 shares of common stock at an exercise price of $15.23 per share, expiring in 2036, which follow the same vesting schedule. After the RSU grant, he beneficially owns 25,388 common shares directly, including 8,141 unvested RSUs, plus the new option award.
Schrodinger, Inc. director Nancy Thornberry received new equity awards as part of her compensation. She was granted 8,141 restricted stock units (RSUs), each representing one share of common stock, increasing her direct holdings to 25,388 common shares after the award.
The RSUs were granted on June 22, 2026 and vest on the twelve‑month anniversary of grant, or earlier if the next annual stockholder meeting occurs first, subject to continued service. Their settlement is deferred until separation from service or certain change in control events. Thornberry was also granted options for 13,313 shares at an exercise price of $15.23 per share, expiring on June 22, 2036, with the option award vesting on the same timetable.
Schrodinger, Inc. director Bridget A. van Kralingen received new equity compensation. She was granted 8,141 restricted stock units, each representing one share of common stock, under the company’s 2022 Equity Incentive Plan. These RSUs vest on the 12‑month anniversary of the June 22, 2026 grant date, or earlier if the next annual stockholder meeting occurs before then, subject to continued service.
She was also granted stock options for 13,313 shares of common stock at an exercise price of $15.23 per share, expiring on June 22, 2036, with the same vesting schedule. Following these awards, she holds 19,640 shares of common stock, including 14,808 unvested RSUs, plus the newly granted options.
Schrodinger, Inc. President & CEO Ramy Farid reported option exercises and related share sales. He exercised stock options to acquire a total of 160,527 shares of common stock at an exercise price of $3.070 per share.
On April 16, 2026, he exercised options for 43,000 shares and sold 43,000 shares at a weighted average price of $12.331 per share. On April 17, 2026, he exercised additional options for 117,527 shares (in two tranches) and sold 43,000 shares at a weighted average price of $12.208 per share.
According to the filing, these transactions were effected under a Rule 10b5-1 trading plan adopted on September 2, 2025. After the transactions, Farid directly holds 330,824 shares of common stock, including 132,634 unvested RSUs, and the reported option grant from May 11, 2016 is fully vested and now exercised.
Schrodinger, Inc. EVP & CFO Rachit Jain reported an open-market sale of 844 shares of common stock on April 16, 2026 at a weighted average price of $12.747 per share, in multiple trades between $12.59 and $12.82. According to the disclosure, this was a broker-assisted transaction executed under a pre-arranged Rule 10b5-1 durable automatic sale instruction and was made solely to cover withholding tax liability from vesting restricted stock units, not a discretionary trade. Following the sale, Jain directly holds 51,752 shares, which includes 45,497 unvested RSUs, indicating the transaction is small relative to his overall equity position.
Schrodinger, Inc. Chief Accounting Officer Jenny Herman reported selling a total of 1,383 shares of common stock in two open-market transactions on March 5 and March 6, 2026, at weighted average prices around $12.84 per share. According to the filing, these sales were executed under a pre-established Rule 10b5-1 automatic sale instruction to cover withholding taxes triggered by vesting of restricted stock units, and were not discretionary trades. After these transactions, Herman directly holds 34,804 shares of common stock, which the filing notes includes 22,597 unvested restricted stock units.
Schrodinger, Inc. EVP & CFO Rachit Jain reported an open-market sale of 1,631 shares of common stock. The sale on March 5, 2026 was executed at a weighted average price of $12.896 per share, with individual trades ranging from $12.75 to $12.98.
According to the disclosure, this sale was made under a durable automatic sale instruction pursuant to Rule 10b5-1 and was a broker-assisted transaction to cover withholding tax obligations arising from the vesting of restricted stock units. The filing notes it was not a discretionary trade by the executive.
After this transaction, Jain directly holds 52,596 shares of Schrodinger common stock, which includes 47,997 unvested restricted stock units.
Schrodinger, Inc. executive Yvonne Tran, EVP, CLO & CPO, reported an open-market sale of common stock linked to tax withholding on vested restricted stock units. On March 5, 2026, she sold 1,094 shares at a weighted average price of $12.895 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2023. The sale was a broker-assisted transaction to satisfy withholding tax obligations and did not represent a discretionary trade. Following this transaction, she beneficially owns 52,683 shares of Schrodinger common stock, including 42,191 unvested RSUs.
Schrodinger, Inc. President & CEO Ramy Farid reported an automatic tax-related stock sale. On this Form 4, he sold 3,661 shares of common stock in an open-market transaction under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2023, to cover withholding taxes from vesting RSUs. The weighted average sale price was $12.906 per share, with individual trades ranging from $12.73 to $13.00. After this transaction, he beneficially owned 330,824 shares of Schrodinger common stock, which includes 132,634 unvested restricted stock units.
Schrodinger, Inc. officer Karen Akinsanya reported an open-market sale of 1,366 shares of common stock at a weighted average price of $12.903 per share. According to the filing, this Rule 10b5-1 transaction was a broker-assisted sale solely to cover withholding taxes on vesting RSUs and was not a discretionary trade. After the sale, she directly owned 69,956 shares, including 63,545 unvested restricted stock units.
Schrodinger, Inc. executive Kenneth Patrick Lorton, EVP, CTO & COO, Software, reported an open-market sale of 1,222 shares of common stock on March 5, 2026. The shares were sold under a pre-arranged Rule 10b5-1 automatic plan to cover withholding taxes from restricted stock unit vesting and were executed as a broker-assisted, non-discretionary transaction at a weighted average price of $12.898 per share. After this sale, Lorton directly held 89,241 shares of common stock, including 49,230 unvested RSUs.
Schrodinger, Inc. officer Robert Lorne Abel reported an open-market sale of 1,300 shares of common stock on March 4, 2026 at $12.81 per share. After this transaction, he directly owned 55,897 shares.
According to the disclosure, the sale was executed under a Rule 10b5-1 trading plan adopted on August 25, 2025 and was a broker-assisted sale to cover withholding tax due upon the vesting of restricted stock units. The filing notes that this did not represent a discretionary trade by the officer and that his holdings include 49,824 unvested RSUs.
Schrodinger, Inc. director Richard Friesner exercised stock options that converted into 160,527 shares of common stock. The options, granted on May 11, 2016, were fully vested and were exercised at a price of $3.07 per share.
Following the transaction, Friesner directly owned 682,224 shares of Schrodinger common stock, which includes 5,997 unvested restricted stock units. He also had indirect ownership of 694,925 shares through the RF 2018 grantor retained annuity trust and 28,328 shares held by his spouse.
Schrodinger, Inc. director and President & CEO Farid Ramy reported a mix of equity awards and a small share sale. He received a stock option for 112,500 shares, vesting 25% on March 2, 2027 with the remainder vesting monthly through March 2, 2030, subject to continued service. He also received several grants and vesting events of common stock and performance-based restricted stock units, and now holds common stock that includes 142,009 unvested RSUs. On the same date, he sold 5,560 shares of common stock at a weighted average price of $11.8977 per share under a pre-arranged Rule 10b5-1 plan to cover withholding taxes from PRSU vesting, which the footnotes state was not a discretionary trade.
Schrödinger, Inc.’s EVP & CFO Rachit Jain received new equity awards. On March 2, 2026, he was granted stock options covering 34,250 shares of common stock at an exercise price of $0.0000 per share, increasing his option holdings to 34,250 shares.
He also received a grant of 17,130 restricted stock units (RSUs), each representing one share of common stock, bringing his common stock holdings to 54,227 shares, which includes 52,660 unvested RSUs. The RSUs vest in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030. The options vest 25% on March 2, 2027, with the remainder vesting in equal monthly installments through March 2, 2030, in each case subject to his continued service with the company.
Tran Yvonne reported acquisition or exercise transactions in this Form 4 filing.
Schrodinger, Inc. executive Yvonne Tran, EVP, CLO & CPO, reported equity awards on March 2, 2026. She received a stock option for 34,250 shares with vesting of 25% on March 2, 2027 and the remainder in monthly installments through March 2, 2030, subject to continued service.
She was also granted 17,130 restricted stock units (RSUs) under the 2022 Equity Incentive Plan that vest in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030, subject to continued service. In addition, 13,788 performance-based RSUs from a March 4, 2024 grant had their performance metrics certified on March 2, 2026 and will vest upon the filing of the company’s Form 10-K for the year ended December 31, 2026, subject to continued service.
Schrodinger, Inc. executive Kenneth Patrick Lorton, EVP, CTO & COO, Software, reported equity awards consisting of stock options and restricted stock units. He received a stock option for 34,250 shares, granted on March 2, 2026, that vests 25% on March 2, 2027, with the remainder vesting in equal monthly installments through March 2, 2030, contingent on continued service.
He also acquired 17,130 RSUs under the company’s 2022 Equity Incentive Plan, vesting in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030, subject to continued service. In addition, 20,682 performance-based RSUs from prior 2024 grants were certified as earned on March 2, 2026 and will vest upon the filing of Schrodinger’s Form 10-K for the year ended December 31, 2026, if he remains with the company.
Schrodinger, Inc. chief accounting officer Jenny Herman reported equity awards consisting of stock options and restricted stock units. On March 2, 2026, she acquired options to purchase 8,220 shares of common stock and 9,590 RSUs, both at no cash cost as compensation.
The 9,590 RSUs were granted under the 2022 Equity Incentive Plan and will vest in four equal installments on March 9, 2027, 2028, 2029 and 2030, subject to continued service. The stock option grant is scheduled to vest 25% on March 2, 2027, with the remaining shares vesting in equal monthly installments through March 2, 2030. Following these awards, Herman directly holds 36,187 shares of common stock, including 26,875 unvested RSUs.
Schrodinger, Inc. executive Karen Akinsanya reported several equity awards and a small sale of shares. On March 2, 2026, she received a stock option for 48,500 shares and multiple grants or vesting events of common stock and restricted stock units under company equity plans, with future vesting stretching through 2030 and tied to performance certifications and continued service. The filing also shows the broker-assisted sale of 2,206 shares of common stock at a weighted average price of $11.992 per share under a pre-established Rule 10b5-1 instruction, executed solely to cover withholding taxes from performance-based RSU vesting and described as non-discretionary.
Schrodinger, Inc. officer Mannix Vartan Aklian reported equity awards consisting of stock options and restricted stock units under the company’s 2022 Equity Incentive Plan, as amended. The filing shows a grant of 34,250 stock options at an exercise price of $0.00 per share, with 25% of the underlying shares scheduled to vest on March 2, 2027 and the remaining shares vesting in equal monthly installments through March 2, 2030, subject to continued service.
In addition, Aklian received a grant of 17,130 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock. These RSUs were granted on March 2, 2026 and are scheduled to vest in equal installments on March 9, 2027, 2028, 2029 and 2030, also subject to continued service with the company. Following this grant, the reporting person holds 31,193 unvested RSUs in total.
Schrodinger, Inc. executive Robert Lorne Abel reported equity awards that increase his direct holdings. He received a stock option covering 34,250 shares, granted at an exercise price of $0.00 per share, scheduled to vest 25% on March 2, 2027 and monthly through March 2, 2030, subject to continued service.
He also acquired 17,130 restricted stock units (RSUs) that vest in four equal installments on March 9 of 2027, 2028, 2029 and 2030, and 20,682 performance-based RSUs tied to previously granted awards for which performance achievement was certified on March 2, 2026. These PRSUs are scheduled to vest upon the filing of the company’s Form 10-K for the year ended December 31, 2026, subject to continued service. Following these awards, his direct holdings include an aggregate of 52,949 unvested RSUs.
Schrodinger, Inc. executive Yvonne Tran, EVP, CLO & CPO, sold 776 shares of common stock on 02/10/2026 at a weighted average price of $13.7956. The sale was executed under a durable Rule 10b5-1 automatic instruction to cover withholding taxes from vesting restricted stock units and was not a discretionary trade. Following this transaction, Tran beneficially owned 22,859 shares, including 14,398 unvested RSUs.
Schrodinger, Inc. executive Kenneth Patrick Lorton reported a small automatic sale of common stock tied to tax withholding. On 02/10/2026, he sold 925 shares of Schrodinger common stock in an open-market transaction at a weighted average price of $13.7338 per share under a pre-established Rule 10b5-1 plan. The sale was executed by a broker to cover withholding taxes arising from the vesting of restricted stock units and is described as non-discretionary. After this transaction, Lorton directly beneficially owned 52,651 shares of common stock, including 14,543 unvested RSUs.
Schrodinger, Inc.’s Chief Accounting Officer Jenny Herman reported an open-market sale of common stock. On February 10, 2026, she sold 752 shares at a weighted average price of $13.7904 under a pre-established Rule 10b5-1 trading plan to cover withholding taxes from RSU vesting.
After this transaction, she directly beneficially owns 26,597 shares of Schrodinger common stock, which includes 17,285 unvested RSUs. The filing notes the sale was not a discretionary trade and that the shares were sold in multiple transactions between $13.71 and $13.85.
Abel Robert Lorne reported open-market sale transactions in a Form 4 filing for SDGR. The filing lists transactions totaling 1,230 shares at a weighted average price of $13.51 per share. Following the reported transactions, holdings were 19,385 shares.
Schrodinger, Inc. (SDGR) reported an insider transaction by its Chief Medical Officer, Margaret Dugan. On 10/16/2025, she sold 1,395 shares of common stock at $21.066 per share, coded “S.”
The filing states the sale was executed under a Rule 10b5-1 automatic instruction adopted on November 13, 2023, and was a broker-assisted sale to cover withholding taxes upon the vesting of restricted stock units. Following the sale, she beneficially owns 24,574 shares, which include 20,000 unvested RSUs. Ownership is listed as direct.